APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prescription Respiratory Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Prescription Respiratory Drugs Industry Growth and Trends Forecast to 2032

22 December 202578 pages

Choose your research edition.

Industry ResearchPrescription Respiratory Drugs Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Prescription Respiratory Drugs Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Prescription Respiratory Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prescription Respiratory Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Prescription Respiratory Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Prescription Respiratory Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prescription Respiratory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prescription Respiratory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prescription Respiratory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prescription Respiratory Drugs include Merck, GlaxoSmithKline, AstraZeneca and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prescription Respiratory Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prescription Respiratory Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prescription Respiratory Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prescription Respiratory Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prescription Respiratory Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prescription Respiratory Drugs Market by Company

Merck

GlaxoSmithKline

AstraZeneca

Boehringer Ingelheim

Prescription Respiratory Drugs Segment by Type

Bronchodilators

Anti-Inflammatories

Mast Stabilizers

Antihistamines

Other Respiratory Drugs

Prescription Respiratory Drugs Segment by Application

E-Commerce

Retail Stores

Drug Stores

Hospital Pharmacies

Prescription Respiratory Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Respiratory Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prescription Respiratory Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Respiratory Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prescription Respiratory Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prescription Respiratory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Bronchodilators Table 2. Major Company of Anti-Inflammatories Table 3. Major Company of Mast Stabilizers Table 4. Major Company of Antihistamines Table 5. Major Company of Other Respiratory Drugs Table 6. Global Prescription Respiratory Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Prescription Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 8. Global Prescription Respiratory Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Prescription Respiratory Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Prescription Respiratory Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Prescription Respiratory Drugs Price by Type (2021-2026) & (US$/unit) Table 12. Global Prescription Respiratory Drugs Sales by Type (2027-2032) & (k units) Table 13. Global Prescription Respiratory Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Prescription Respiratory Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Prescription Respiratory Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Prescription Respiratory Drugs Price by Type (2027-2032) & (US$/unit) Table 17. North America Prescription Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 18. North America Prescription Respiratory Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Prescription Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 20. Europe Prescription Respiratory Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Prescription Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Prescription Respiratory Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Prescription Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 24. Latin America Prescription Respiratory Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Prescription Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Prescription Respiratory Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Prescription Respiratory Drugs Industry Trends Table 28. Prescription Respiratory Drugs Industry Drivers Table 29. Prescription Respiratory Drugs Industry Opportunities and Challenges Table 30. Prescription Respiratory Drugs Industry Restraints Table 31. Global Prescription Respiratory Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Prescription Respiratory Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Prescription Respiratory Drugs Sales by Company (2021-2026) & (k units) Table 34. Global Prescription Respiratory Drugs Sales Share by Company (2021-2026) Table 35. Global Prescription Respiratory Drugs Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Prescription Respiratory Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Prescription Respiratory Drugs Major Company Production Sites and Headquarters Table 38. Global Prescription Respiratory Drugs Company, Product Type & Application Table 39. Global Prescription Respiratory Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Prescription Respiratory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Prescription Respiratory Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Prescription Respiratory Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Prescription Respiratory Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Prescription Respiratory Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Prescription Respiratory Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Prescription Respiratory Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Prescription Respiratory Drugs Sales by Region (2027-2032) & (k units) Table 49. Global Prescription Respiratory Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Prescription Respiratory Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Prescription Respiratory Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Prescription Respiratory Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Prescription Respiratory Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Prescription Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 55. Global Prescription Respiratory Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Prescription Respiratory Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Prescription Respiratory Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Prescription Respiratory Drugs Price by Application (2021-2026) & (US$/unit) Table 59. Global Prescription Respiratory Drugs Sales by Application (2027-2032) & (k units) Table 60. Global Prescription Respiratory Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Prescription Respiratory Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Prescription Respiratory Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Prescription Respiratory Drugs Price by Application (2027-2032) & (US$/unit) Table 64. North America Prescription Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 65. North America Prescription Respiratory Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Prescription Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 67. Europe Prescription Respiratory Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Prescription Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Prescription Respiratory Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Prescription Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 71. Latin America Prescription Respiratory Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Prescription Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Prescription Respiratory Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Prescription Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck Prescription Respiratory Drugs Product Portfolio Table 78. Merck Recent Development Table 79. GlaxoSmithKline Company Information Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline Prescription Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline Prescription Respiratory Drugs Product Portfolio Table 83. GlaxoSmithKline Recent Development Table 84. AstraZeneca Company Information Table 85. AstraZeneca Business Overview Table 86. AstraZeneca Prescription Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. AstraZeneca Prescription Respiratory Drugs Product Portfolio Table 88. AstraZeneca Recent Development Table 89. Boehringer Ingelheim Company Information Table 90. Boehringer Ingelheim Business Overview Table 91. Boehringer Ingelheim Prescription Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Boehringer Ingelheim Prescription Respiratory Drugs Product Portfolio Table 93. Boehringer Ingelheim Recent Development Table 94. North America Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 95. North America Prescription Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 96. North America Prescription Respiratory Drugs Sales Market Share by Country (2021-2026) Table 97. North America Prescription Respiratory Drugs Sales Forecast by Country (2027-2032) & (k units) Table 98. North America Prescription Respiratory Drugs Sales Market Share Forecast by Country (2027-2032) Table 99. North America Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 100. North America Prescription Respiratory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 101. North America Prescription Respiratory Drugs Market Share by Country (2021-2026) Table 102. North America Prescription Respiratory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 103. North America Prescription Respiratory Drugs Market Share Forecast by Country (2027-2032) Table 104. Europe Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 105. Europe Prescription Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 106. Europe Prescription Respiratory Drugs Sales Market Share by Country (2021-2026) Table 107. Europe Prescription Respiratory Drugs Sales Forecast by Country (2027-2032) & (k units) Table 108. Europe Prescription Respiratory Drugs Sales Market Share Forecast by Country (2027-2032) Table 109. Europe Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. Europe Prescription Respiratory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 111. Europe Prescription Respiratory Drugs Market Share by Country (2021-2026) Table 112. Europe Prescription Respiratory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. Europe Prescription Respiratory Drugs Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific Prescription Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 116. Asia-Pacific Prescription Respiratory Drugs Sales Market Share by Country (2021-2026) Table 117. Asia-Pacific Prescription Respiratory Drugs Sales Forecast by Country (2027-2032) & (k units) Table 118. Asia-Pacific Prescription Respiratory Drugs Sales Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Prescription Respiratory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 121. Asia-Pacific Prescription Respiratory Drugs Market Share by Country (2021-2026) Table 122. Asia-Pacific Prescription Respiratory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Asia-Pacific Prescription Respiratory Drugs Market Share Forecast by Country (2027-2032) Table 124. Latin America Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. Latin America Prescription Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 126. Latin America Prescription Respiratory Drugs Sales Market Share by Country (2021-2026) Table 127. Latin America Prescription Respiratory Drugs Sales Forecast by Country (2027-2032) & (k units) Table 128. Latin America Prescription Respiratory Drugs Sales Market Share Forecast by Country (2027-2032) Table 129. Latin America Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Latin America Prescription Respiratory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 131. Latin America Prescription Respiratory Drugs Market Share by Country (2021-2026) Table 132. Latin America Prescription Respiratory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Latin America Prescription Respiratory Drugs Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa Prescription Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 136. Middle East and Africa Prescription Respiratory Drugs Sales Market Share by Country (2021-2026) Table 137. Middle East and Africa Prescription Respiratory Drugs Sales Forecast by Country (2027-2032) & (k units) Table 138. Middle East and Africa Prescription Respiratory Drugs Sales Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Prescription Respiratory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Prescription Respiratory Drugs Market Share by Country (2021-2026) Table 142. Middle East and Africa Prescription Respiratory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Middle East and Africa Prescription Respiratory Drugs Market Share Forecast by Country (2027-2032) Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Prescription Respiratory Drugs Distributors List Table 147. Prescription Respiratory Drugs Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Prescription Respiratory Drugs Image Figure 2. Global Prescription Respiratory Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prescription Respiratory Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Prescription Respiratory Drugs Sales (2021-2032) & (k units) Figure 5. Bronchodilators Image Figure 6. Global Bronchodilators Sales YoY Growth (2021-2032) & (k units) Figure 7. Anti-Inflammatories Image Figure 8. Global Anti-Inflammatories Sales YoY Growth (2021-2032) & (k units) Figure 9. Mast Stabilizers Image Figure 10. Global Mast Stabilizers Sales YoY Growth (2021-2032) & (k units) Figure 11. Antihistamines Image Figure 12. Global Antihistamines Sales YoY Growth (2021-2032) & (k units) Figure 13. Other Respiratory Drugs Image Figure 14. Global Other Respiratory Drugs Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Prescription Respiratory Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Prescription Respiratory Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Prescription Respiratory Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Prescription Respiratory Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Prescription Respiratory Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Prescription Respiratory Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Prescription Respiratory Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Prescription Respiratory Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Prescription Respiratory Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Prescription Respiratory Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Prescription Respiratory Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Prescription Respiratory Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Prescription Respiratory Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. E-Commerce Image Figure 30. Global E-Commerce Sales YoY Growth (2021-2032) & (k units) Figure 31. Retail Stores Image Figure 32. Global Retail Stores Sales YoY Growth (2021-2032) & (k units) Figure 33. Drug Stores Image Figure 34. Global Drug Stores Sales YoY Growth (2021-2032) & (k units) Figure 35. Hospital Pharmacies Image Figure 36. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Prescription Respiratory Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Prescription Respiratory Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Prescription Respiratory Drugs Sales Market Share in Volume by Application in 2025 Figure 40. North America Prescription Respiratory Drugs Sales Market Share in Value by Application in 2025 Figure 41. Europe Prescription Respiratory Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Europe Prescription Respiratory Drugs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Prescription Respiratory Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Prescription Respiratory Drugs Sales Market Share in Value by Application in 2025 Figure 45. Latin America Prescription Respiratory Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Prescription Respiratory Drugs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Prescription Respiratory Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Prescription Respiratory Drugs Sales Market Share in Value by Application in 2025 Figure 49. North America Prescription Respiratory Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Prescription Respiratory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Prescription Respiratory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Prescription Respiratory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Prescription Respiratory Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Prescription Respiratory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Prescription Respiratory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Prescription Respiratory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Prescription Respiratory Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Prescription Respiratory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Prescription Respiratory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Prescription Respiratory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Prescription Respiratory Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Prescription Respiratory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Prescription Respiratory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Prescription Respiratory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Prescription Respiratory Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Prescription Respiratory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Prescription Respiratory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Prescription Respiratory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Prescription Respiratory Drugs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Prescription Respiratory Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Bronchodilators
  • Anti-Inflammatories
  • Mast Stabilizers
  • Antihistamines
  • Other Respiratory Drugs
Applications
  • E-Commerce
  • Retail Stores
  • Drug Stores
  • Hospital Pharmacies
Companies covered
  • Merck
  • GlaxoSmithKline
  • AstraZeneca
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prescription Respiratory Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prescription Respiratory Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prescription Respiratory Drugs Market by Type
  6. 1.3.1 Bronchodilators
  7. 1.3.2 Anti-Inflammatories
  8. 1.3.3 Mast Stabilizers
  9. 1.3.4 Antihistamines
  10. 1.3.5 Other Respiratory Drugs
  11. 1.4 Global Prescription Respiratory Drugs Market Size by Type
  12. 1.4.1 Global Prescription Respiratory Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Prescription Respiratory Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Prescription Respiratory Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Prescription Respiratory Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Prescription Respiratory Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Prescription Respiratory Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Prescription Respiratory Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Prescription Respiratory Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prescription Respiratory Drugs Industry Trends
  2. 2.2 Prescription Respiratory Drugs Industry Drivers
  3. 2.3 Prescription Respiratory Drugs Industry Opportunities and Challenges
  4. 2.4 Prescription Respiratory Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prescription Respiratory Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Prescription Respiratory Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Prescription Respiratory Drugs Price (2021-2026)
  4. 3.4 Global Prescription Respiratory Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prescription Respiratory Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Prescription Respiratory Drugs Company, Product Type & Application
  7. 3.7 Global Prescription Respiratory Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prescription Respiratory Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prescription Respiratory Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prescription Respiratory Drugs Tier 1, Tier 2, and Tier 3
4 Prescription Respiratory Drugs Regional Status and Outlook
  1. 4.1 Global Prescription Respiratory Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prescription Respiratory Drugs Historic Market Size by Region
  3. 4.2.1 Global Prescription Respiratory Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prescription Respiratory Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prescription Respiratory Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prescription Respiratory Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Prescription Respiratory Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prescription Respiratory Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prescription Respiratory Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prescription Respiratory Drugs by Application
  1. 5.1 Prescription Respiratory Drugs Market by Application
  2. 5.1.1 E-Commerce
  3. 5.1.2 Retail Stores
  4. 5.1.3 Drug Stores
  5. 5.1.4 Hospital Pharmacies
  6. 5.2 Global Prescription Respiratory Drugs Market Size by Application
  7. 5.2.1 Global Prescription Respiratory Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Prescription Respiratory Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Prescription Respiratory Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Prescription Respiratory Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Prescription Respiratory Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Prescription Respiratory Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Prescription Respiratory Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Prescription Respiratory Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Prescription Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Prescription Respiratory Drugs Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 GlaxoSmithKline
  8. 6.2.1 GlaxoSmithKline Company Information
  9. 6.2.2 GlaxoSmithKline Business Overview
  10. 6.2.3 GlaxoSmithKline Prescription Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Prescription Respiratory Drugs Product Portfolio
  12. 6.2.5 GlaxoSmithKline Recent Developments
  13. 6.3 AstraZeneca
  14. 6.3.1 AstraZeneca Company Information
  15. 6.3.2 AstraZeneca Business Overview
  16. 6.3.3 AstraZeneca Prescription Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca Prescription Respiratory Drugs Product Portfolio
  18. 6.3.5 AstraZeneca Recent Developments
  19. 6.4 Boehringer Ingelheim
  20. 6.4.1 Boehringer Ingelheim Company Information
  21. 6.4.2 Boehringer Ingelheim Business Overview
  22. 6.4.3 Boehringer Ingelheim Prescription Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Boehringer Ingelheim Prescription Respiratory Drugs Product Portfolio
  24. 6.4.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Prescription Respiratory Drugs Sales by Country
  2. 7.1.1 North America Prescription Respiratory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prescription Respiratory Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Prescription Respiratory Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prescription Respiratory Drugs Market Size by Country
  6. 7.2.1 North America Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prescription Respiratory Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Prescription Respiratory Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prescription Respiratory Drugs Sales by Country
  2. 8.1.1 Europe Prescription Respiratory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prescription Respiratory Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Prescription Respiratory Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prescription Respiratory Drugs Market Size by Country
  6. 8.2.1 Europe Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prescription Respiratory Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prescription Respiratory Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prescription Respiratory Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Prescription Respiratory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prescription Respiratory Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prescription Respiratory Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prescription Respiratory Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prescription Respiratory Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prescription Respiratory Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prescription Respiratory Drugs Sales by Country
  2. 10.1.1 South America Prescription Respiratory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prescription Respiratory Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Prescription Respiratory Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prescription Respiratory Drugs Market Size by Country
  6. 10.2.1 South America Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prescription Respiratory Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Prescription Respiratory Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prescription Respiratory Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Prescription Respiratory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prescription Respiratory Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prescription Respiratory Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prescription Respiratory Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Prescription Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prescription Respiratory Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prescription Respiratory Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prescription Respiratory Drugs Value Chain Analysis
  2. 12.1.1 Prescription Respiratory Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prescription Respiratory Drugs Production Mode & Process
  7. 12.2 Prescription Respiratory Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prescription Respiratory Drugs Distributors
  10. 12.2.3 Prescription Respiratory Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst